ExamPat

Alan D Diamond

USPTO Patent Examiner·Active 2012 to 2026

Alan D Diamond is a USPTO patent examiner who has handled 74 ex parte reexaminations between 2012 and 2026, with 11 currently open. These reexams concentrate in Life Sciences & Consumer, Chemistry & Materials, and Electrical & Electronic. ExamPat indexes the full prosecution record for each of these cases, including office-action grounds, certificate outcomes, and downstream PTAB and federal-circuit decisions.

Filings by year

10
12
3
13
9
14
7
15
5
17
3
18
4
19
3
20
3
21
8
22
6
23
2
24
6
25
5
26

Technology mix

Life Sciences & Consumer32 (43%)
Chemistry & Materials27 (36%)
Electrical & Electronic13 (18%)
Mechanical Engineering1 (1%)
Physics & Instruments1 (1%)

Compare against all examiners

Eight side-by-side metrics: case volume, pendency, OAs per reexam, rejection mix, SNQ denial rate, certification rate, and PTAB appeal rate, with a Δ column showing where this examiner runs higher or lower than the corpus.

  • Average and median pendency, both for this examiner and the corpus
  • Rejection basis split (102 / 103 / 112) head-to-head
  • Certification, SNQ denial, and PTAB appeal rates

Certificate outcome distribution

How this examiner's certificates split across the six possible outcomes: all claims confirmed, confirmed with amendment, confirmed with new claims, mixed, or all claims canceled. Includes share comparison to the corpus distribution.

  • Count and share for each of the six outcome buckets
  • Δ vs. corpus distribution in percentage points
  • Useful for setting realistic patent-owner expectations

Event-to-event timing

Median time for this examiner's cases at each prosecution stage, from filing to first office action, filing to NIRC, and filing to certificate, with corpus comparison and sample size.

  • Median in months per transition
  • Side-by-side with the corpus median
  • n column showing how many of this examiner's cases completed each transition

vs. all examiners

Certificate outcome distribution

Event-to-event timing (median)

Recent reexaminations (showing 25 of 74)

View all in dashboard →
Control #FiledPatentTitlePendencyStatus
90/016,207Apr 24, 202612,586,696MAGNETIZED CABLES FOR IMPROVED CABLE MANAGEMENT—Open
90/016,178Apr 14, 202612,329,738UROLITHIN A AND A COMPOSITION CONTAINING SAME FOR EXTERNAL USE IN INFLAMMATIONS OF VARIOUS ETIOLOGIES—Open
90/016,021Mar 2, 202611,207,280EPINEPHRINE COMPOSITIONS AND CONTAINERS—Open
90/015,927Jan 30, 202612,533,328EPINEPHRINE COMPOSITIONS AND CONTAINERS—Open
90/015,899Jan 21, 20269,349,655METHOD FOR MECHANICAL STRESS ENHANCEMENT IN SEMICONDUCTOR DEVICES—Open
90/015,851Dec 31, 202512,508,238EPINEPHRINE COMPOSITIONS AND CONTAINERS—Open
90/015,635Oct 24, 202511,147,878ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS—Open
90/015,512Sep 12, 202511,230,521MONOAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME—Open
90/015,486Aug 28, 202511,147,782GHB FORMULATION AND METHOD FOR ITS MANUFACTURE—Open
90/015,342Jun 25, 20259,605,152ASPHALT COMPOSITIONS FOR ROOFING APPLICATIONS, METHODS FOR MAKING THE SAME, AND FILLED ASPHALT MATERIAL COMPRISING THE SAME—Open
90/019,810Jan 13, 20259,814,256METHOD FOR PROCESSING CRUSTACEANS TO PRODUCE LOW FLUORIDE/LOW TRIMETHYL AMINE PRODUCTS THEREOF8 moClosed
90/019,744Nov 26, 202410,392,353NOVEL PROCESSES FOR MAKING SUBSTITUTED QUINAZOLINE COMPOUNDS USING HYDROGEN BONDING CATALYSTS10 moClosed
90/019,368Jan 8, 202411,655,240CRYSTAL FORM OF COMPOUND AND FUMARIC ACID, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING CORONAVIRUS-INDUCED DISEASES25 moClosed
90/019,345Dec 20, 202311,116,740Methods for Use in Support of Planned Supplement and Food Ingredient Products for Diagnosis and Treatment of Metabolic Syndrome10 moClosed
90/019,314Nov 30, 202311,560,343Process for capture of carbon dioxide from air and the direct conversion of carbon dioxide into fuels and chemicals11 moClosed
90/019,315Nov 30, 202311,565,982Process for Conversion of Carbon Dioxide and Power into Fuels and Chemicals.9 moClosed
90/015,307Oct 2, 202311,661,402PSMA-TARGETING COMPOUNDS AND USES THEREOF6 moClosed
90/015,257Jul 11, 202311,655,383PHOTOCHROMIC COMPOSITIONS, MARKERS CONTAINING THE SAME, AND SYSTEMS AND METHODS FOR THEIR USE8 moClosed
90/015,243Jun 1, 202311,279,658COMPOSITIONS FOR IMPROVED CONCRETE PERFORMANCE8 moClosed
90/015,179Dec 20, 202211,292,725METHOD FOR RECOVERING LITHIUM HYDROXIDE23 moClosed
90/015,145Oct 27, 202211,141,420Flavanones For Use In Treating Visceral Hypersensitivity13 moClosed
90/015,136Oct 17, 20229,102,585EFFICIENT CONTINUOUS PROCESS FOR MANUFACTURING OF 4-AMINODIPHENYLAMINE FROM ANILINE AND NITROBENZENE9 moClosed
90/015,089Aug 9, 202211,186,598Radioactive Phospholipid Metal Chelates for Cancer Imaging and Therapy11 moClosed
90/015,075Jul 20, 20229,119,823NITRITE FORMULATIONS AND THEIR USE AS NITRIC OXIDE PRODRUGS17 moClosed
90/015,001Apr 8, 20229,241,999Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system34 moClosed

Other USPTO reexam examiners

Get the full reexam analytics

Compare Alan D Diamond against the full corpus, see the certificate-outcome split, drill into event timing, filter the case list, and export. Free to sign up.